ChemPartner ESG Policy and Guidelines
Sustainability Philosophy: ChemPartner integrates environmental responsibility, social responsibility, and corporate governance into the very DNA of the company’s development. We embody our core values of “Science as the Foundation, Responsibility as the Guiding Principle” through concrete actions. Committed to deep-rooted green and sustainable development, we act as a responsible corporate citizen to promote high-quality corporate growth and achieve harmony between the enterprise, society, and the environment. Our ultimate goal is to realize our great mission: “To empower pharmaceutical innovation comprehensively, allowing life to meet hope sooner.”
I. Environmental (E)
Our Philosophy
In an era where green development has become a global consensus, ChemPartner regards environmental protection as a core responsibility of corporate development. Adhering to the scientific development concept of “comprehensive, coordinated, and sustainable development,” we are dedicated to systematically building a green operational system through systematic environmental management, scientific pollution control, proactive climate change initiatives, and stringent safety production management. We strive to contribute to the preservation of the ecological environment and the advancement of sustainable development, aiming to “become a trusted partner for innovators in the global life sciences field.”
Our Management
The company has established a comprehensive environmental management organizational structure and strictly enforces national and local environmental protection laws and regulations. The Executive President serves as the highest-ranking official responsible for environmental protection, with the EHS Department acting as the core executing body. Department heads and laboratory managers at all levels have clearly defined environmental responsibilities. By formulating policies such as the Environmental Protection Responsibility System and the Energy Conservation and Consumption Reduction Management Standards, we incorporate environmental goals into performance assessments, ensuring environmental protection efforts progress in tandem with production and operations.
Our Goals and Commitments
Strictly comply with national and local environmental regulations, ensuring 100% compliance for exhaust gas, wastewater, and noise emissions.
Continuously optimize the energy structure, enhance energy efficiency, and reduce carbon emission intensity.
Promote circular economy practices, improve water resource efficiency, and increase the utilization rate of renewable materials.
Achieve a 100% compliant disposal rate for hazardous waste and eliminate environmental violations.
Our Key Initiatives
Environmental Risk Prevention & Control: Establish procedures for identifying and evaluating environmental factors, updating these factors annually and formulating corresponding management measures.
Pollution Control: Implement systematic monitoring of air, water, and noise pollution, entrusting qualified third-party organizations for regular testing.
Energy Conservation & Emission Reduction: Utilize high-efficiency equipment (e.g., chillers with COP ≥ 5.6), variable air volume control systems, and promote daily energy-saving practices like “turn off lights when leaving.”
Water Resource Management: Implement measures such as cooling tower water optimization, concentrated water reuse from purified water systems, and boiler condensate recovery.
Emergency Management: Develop Contingency Plans for Environmental Emergencies and conduct regular drills for scenarios like fires and chemical spills.
Annual Key Performance Indicators
Indicator
Total Environmental Investment: RMB 7.4996 million
Environmental Training Coverage: 100%
Environmental Violations: 0 incidents
Cumulative Renewable Materials Used: 8.21 tons
II. Social (S)
Our Philosophy
ChemPartner adheres to the values of “precision, efficiency, cooperation, and mutual benefit.” To achieve sustainable high-quality development and long-term value creation, we continuously optimize and enhance our core business operations. The company pursues an innovation-driven strategy, achieving breakthroughs in R&D, supply chain management, quality control, and digital operations, committed to creating greater value for the industry and society. Furthermore, ChemPartner places great emphasis on employee development and social contribution, aiming to advance the industry, ensure stable growth in a competitive market, enhance overall corporate service and social responsibility performance, and solidify long-term sustainable competitiveness.
Our Management
The company has built a management system covering the entire employee lifecycle, systematically advancing talent strategy from compliant hiring and compensation incentives to training development and welfare benefits. Concurrently, we integrate social responsibility standards throughout the supply chain lifecycle and have established diversified stakeholder communication mechanisms to ensure timely responses to all stakeholder needs.
Our Goals and Commitments
Provide employees with a fair, safe, and inclusive work environment, safeguarding occupational health and safety with a target of zero occupational diseases.
Establish a competitive compensation and incentive system, fostering mutual growth for employees and the company.
Promote sustainable supply chain development, signing social responsibility agreements with 100% of key suppliers.
Deepen industry-academia-research collaboration to aid innovation and upgrading in the biopharmaceutical industry.
Our Key Initiatives
Innovative R&D: The company intensifies efforts in technological innovation management, leveraging its advanced R&D platforms and high-caliber scientific teams. Through robust R&D incentives and intellectual property management mechanisms, it stimulates research vitality, offering global clients a fully integrated, end-to-end solution from early discovery to commercial manufacturing.
Digital Operations: Relying on advanced information technology platforms, the company has achieved digital transformation across business processes and established a robust information security protection system. Through intelligent data analysis, automated management, and efficient collaboration, the company significantly enhances operational efficiency while ensuring the security of critical data and information, providing a solid foundation for sustained innovation and stable development.
Employee Development: Established five career development pathways (Management, R&D, Functions, Sales, Production); implemented the “Set Sail Program” for specialized talent cultivation; built an online training platform achieving 100% training coverage and 100% assessment pass rate.
Compensation & Benefits: Established a diversified compensation system comprising base salary, performance bonus, and long-term incentive retention awards; offers comprehensive benefits including social insurance, housing fund, paid annual leave, and nursing rooms.
Occupational Health: Formulated the Occupational Health Medical Management Procedure, implementing full-cycle occupational health check-ups (pre-employment, during employment, and post-employment) with 100% coverage.
Democratic Communication: Established communication mechanisms such as employee representative congresses, employee forums, and satisfaction surveys, achieving an annual employee satisfaction rate of 89.2%.
Supply Chain Responsibility: Issued the Supplier Social Responsibility Code of Conduct, integrating ESG into the entire supplier lifecycle (admission, evaluation, audit). Conducted social and environmental impact assessments for 126 suppliers and signed environmental/labor clauses with 70% of suppliers.
Industry Advancement: Established strategic partnerships with institutions such as National University of Malaysia, University of Newcastle (Australia), East China Normal University, and Hong Kong Polytechnic University; hosted industry events like the DMPK Government-Industry-Academia Roundtable.
Annual Key Performance Indicators
Indicator
R&D Personnel Ratio: 79.22%
Female Employee Ratio: 56%
Valid Patents Held: 69
Training Sessions: 420 sessions
Employee Satisfaction: ~90%
Occupational Disease Incidence: 0
Local Supplier Procurement Ratio: 56%
III. Governance (G)
Our Philosophy
ChemPartner upholds the corporate governance philosophy of “compliance, transparency, collaboration, and innovation,” dedicated to building a scientific, efficient, standardized, and transparent modern corporate governance structure. The company strictly adheres to laws and regulations, improves the “three committees and management” governance mechanism, strengthens risk management and business ethics, and solidifies the foundation for long-term development with a transparent and standardized management system. Concurrently, the company prioritizes investor relations management, safeguarding investor rights through robust systems and multi-channel communication. It upholds the bottom line of business ethics, resolutely opposes corruption and unfair competition to maintain a fair and equitable market environment, and reinforces risk management and optimizes internal audit mechanisms to secure the company’s stable development.
Our Management
The company has established a three-tier sustainable development management system: “Board of Directors for strategic oversight, Strategy Committee for comprehensive management, and ESG Working Group for collaborative execution.” The Board of Directors has three specialized committees: Audit Committee, Remuneration and Appraisal Committee, and Strategy Committee. Independent directors account for 66.67% of the board, ensuring scientific and independent decision-making.
Our Goals and Commitments
Ensure standardized operation of the “three committees” (Shareholders’ Meeting, Board of Directors, Supervisory Committee) with a 100% attendance rate for board members.
Achieve truthful, accurate, complete, and timely information disclosure, ensuring investors have equal access to information.
Establish a zero-tolerance anti-corruption mechanism, eliminating commercial bribery and unfair competition.
Obtain ISO/IEC 27001 certification to ensure the effective operation of the information security management system.
Continuously optimize the internal control system to ensure operational compliance and asset security.
Our Key Initiatives
Corporate Governance: Standardized operation of the Shareholders’ Meeting, Board of Directors, and Supervisory Committee (“three committees”); convened 4 shareholders’ meetings, 9 board meetings, and 7 supervisory committee meetings annually, with 100% board member attendance.
Investor Relations: Formulated the Investor Relations Management System, engaging in multi-channel communication (earnings briefings, roadshows, interactive platforms). Responded to 80 investor inquiries with a 100% response rate.
Information Disclosure: Strictly adhered to the Management Measures for Information Disclosure of Listed Companies, disclosing 176 announcements throughout the year, ensuring information authenticity, accuracy, completeness, and timeliness.
Business Ethics: Formulated the Code of Ethical Conduct, conducted anti-corruption and anti-bribery training, with 100% of major suppliers signing the Anti-Commercial Bribery Agreement.
Risk Management: Established the Internal Audit System, with the Internal Audit Department submitting an internal control evaluation report to the Audit Committee annually; conducts business ethics audits and supplier audits.
Information Security: Obtained ISO/IEC 27001 Information Security Management System certification; established an information security management and control process based on the PDCA model; achieved zero information security incidents for the year.
Annual Key Performance Indicators
Indicator
Board Member Attendance Rate: 100%
Information Disclosure Announcements: 176
Investor Inquiry Response Rate: 100%
Anti-Corruption Training Coverage: 100%
Supplier Anti-Bribery Agreement Signing Rate: 100%
Information Security Incidents: 0
Information Security Training Hours: 1,714 hours
IV. Featured Section: Upholding Scientific Ethics and Practicing Animal Care
ChemPartner consistently regards laboratory animal welfare as a critical component of its corporate social responsibility, striving to balance scientific innovation with animal protection.
Our Commitments
Strictly adhere to domestic and international animal welfare regulations, following the “3R Principles” (Replacement, Reduction, Refinement).
Maintain AAALAC International accreditation; hold 3 Laboratory Animal Use Permits.
Establish an IACUC (Institutional Animal Care and Use Committee) oversight mechanism to ensure experimental processes meet ethical standards.
Our Practices
Formulated comprehensive animal health management procedures covering abnormal identification, diagnosis, treatment, and humane endpoints.
Conducted 7 specialized animal welfare training sessions with nearly 1,100 participants.
Organized “World Laboratory Animal Day” themed activities to honor laboratory animals that have contributed to human health.
Business Ethics
I. Core Principles and Values
Adhering to the core principle of “Integrity in Operations, Compliance with Transparency,” guided by the Code of Ethical Conduct, the company maintains a “zero-tolerance” policy towards any form of corruption, bribery, or unfair competition. We are committed to building a fair, just, and open business environment, safeguarding the legitimate rights and interests of stakeholders including shareholders, customers, and suppliers, thereby solidifying the ethical foundation for sustainable corporate development.
II. Legal Compliance
ChemPartner regards legal and regulatory compliance as the core bottom line of its operations, having established a legal compliance management system covering its global business. We strictly comply with domestic regulations such as China’s Company Law, Securities Law, and Anti-Monopoly Law, as well as globally applicable rules like the US National Labor Relations Act and relevant guidelines from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), ensuring all operational aspects are legal and compliant.
We have established a compliance management structure featuring “Board-level oversight, Legal Department leadership, and collaboration across business units.” Through regular training on regulatory interpretation and case analysis, we enhance compliance awareness across the organization. Given the specifics of the pharmaceutical industry, we have developed specialized compliance processes in key areas such as drug R&D, manufacturing outsourcing, and supply chain collaboration, including supplier qualification reviews and clinical trial compliance reviews, ensuring the entire business chain meets industry regulatory requirements.
III. Data Protection
Considering data security and privacy protection as core competitive strengths, we adhere to the ISO/IEC 27001 Information Security Management System standard. We have established a hierarchical information security management organizational structure encompassing decision-making, management supervision, and execution levels, with clearly defined security responsibilities at each level.
Policies such as the Information Security Management System General Outline and Information Security Incident Management Measures are in place. We have established a full-process management and control process based on the “PDCA” model, including risk assessment, system implementation, operational monitoring, and continuous improvement. Technical measures like data platform construction, role-based access control, and endpoint device security updates safeguard core data including customer information, R&D data, and trade secrets.
We strengthen enterprise-wide data protection training through programs such as comprehensive cybersecurity awareness training and specialized privacy protection training, covering topics like phishing email identification, password management, and public network usage norms, achieving an employee coverage rate of 94.8%.
IV. Intellectual Property Protection
A robust intellectual property management system has been established, integrating IP protection throughout the R&D process to provide solid support for technological innovation. We manage the full lifecycle of patents (application, maintenance, commercialization) and actively promote patent portfolio development in core areas like medicinal chemistry and biologics R&D, while also comprehensively protecting trademarks, copyrights, and other IP rights.
During the reporting period, the company held 69 valid patents, 9 copyrights, and 127 trademarks; additionally, 5 invention patents were granted, 13 new trademarks were added, and 22 invention patent applications were filed. Through specialized training on patent mining and technical disclosure writing, we enhance the IP awareness and practical skills of research personnel, facilitating the legal transformation and application of innovative outcomes.
We strictly comply with IP-related laws and regulations. In collaborative R&D and supply chain partnerships, rights and obligations regarding IP are clearly defined through confidentiality agreements and IP ownership agreements, preventing infringement risks while respecting the IP achievements of partners and the industry.
V. Global Quality Regulatory Standards
Adhering to the “full lifecycle quality management” philosophy, we have established a Quality Management System (QMS) that meets international standards, covering the entire process from material procurement and R&D experimentation to production delivery. We strictly follow the requirements of domestic and international authorities such as the National Medical Products Administration (NMPA), the US Food and Drug Administration (FDA), and the International Council for Harmonisation (ICH), ensuring product and service quality standards are met.
A differentiated quality training system has been developed, providing specialized training on Standard Operating Procedures (SOPs), GMP fundamentals, and product process protocols for new hires, transferred employees, and current staff, including topics like fermentation process fundamentals and regulations for biologics registration applications, ensuring that all personnel possess the required quality awareness and professional competence.
A customer satisfaction management mechanism is in place, encompassing customer feedback collection, product complaint handling, and periodic satisfaction evaluations, enabling continuous improvement of service processes and quality control measures. The Product Complaint Management Procedure ensures timely responses and proper handling of customer feedback, safeguarding customer interests and product quality stability.
VI. Business Ethics and Anti-Corruption
Upholding the business ethics principle of “Integrity in Operations, Zero Tolerance for Corruption,” guided by the Code of Ethical Conduct, we have established an anti-corruption management system covering internal operations and the supply chain. Key processes such as procurement and collaboration are strictly managed through measures like open tendering and transparent procurement to mitigate conflicts of interest.
We have signed Anti-Commercial Bribery Agreements with all major suppliers, achieving a 100% signing rate. Throughout the supply chain lifecycle, business integrity is incorporated into the supplier evaluation system to foster an ethical supply chain. Regular anti-corruption and anti-bribery training, including case analyses during monthly management meetings, is conducted to interpret policies and industry cases, enhancing integrity awareness across the organization.
A mechanism for reporting and investigating misconduct is established. While protecting personal privacy, the company thoroughly investigates known or suspected improper activities and requires full cooperation from all employees and directors, creating a culture of integrity.
Simultaneously, we strictly adhere to market competition rules, following the Anti-Monopoly Law and related regulations. Through anti-monopoly compliance training and internal review mechanisms, we strive to eliminate unfair competition practices and uphold a fair market order.
VII. R&D Ethics Standards
Scientific ethics and R&D morality serve as the fundamental principles for our research activities, with particular emphasis on laboratory animal welfare. We have established a comprehensive animal welfare management system, strictly adhering to the “3R Principles” (Replacement, Reduction, Refinement) to minimize animal use through alternative methods and reduce animal suffering through optimized experimental designs, ensuring humane treatment of laboratory animals.
An Institutional Animal Care and Use Committee (IACUC) has been established, responsible for reviewing animal experiment protocols, evaluating animal care and use, and handling related complaints. Committee membership includes scientific researchers, non-scientific personnel, and public representatives, ensuring professional and impartial oversight. The company’s three Laboratory Animal Use Permits have successfully passed the five-year re-evaluation process, and we maintain AAALAC International accreditation.
We conduct diverse R&D ethics training and awareness activities, including specialized animal welfare training and World Laboratory Animal Day events. Through lectures, commitment signings, and ceremonies at the animal memorial monument, we convey scientific ethical principles and enhance the moral awareness and sense of responsibility among R&D personnel.
VIII. Environment, Health, and Safety (EHS)
Regarding Environment, Health, and Safety as a core responsibility for sustainable development, we have established an EHS management system based on “full participation and full-process control.” Responsibilities are clearly defined at all levels: the Executive President is the highest-ranking official responsible for environmental protection, the EHS Department is the core executing body, and department heads, laboratory managers, and frontline employees each have defined roles to ensure effective implementation of environmental protection and safety measures.
(A) Environmental Management
Policies such as the Environmental Protection Responsibility System are formulated, integrating environmental goals into the performance appraisal system. Specific measures include pollution reduction programs, environmental monitoring, and hazardous waste management. During the reporting period, the company and its subsidiaries invested a total of RMB 7,499,607.68 in environmental protection. We promote green and low-carbon transformation by optimizing the energy structure, improving waste management capabilities, and reducing carbon emissions.
Pollution control is systematically advanced through mechanisms covering wastewater,废气 (exhaust gas), noise, and solid waste. Wastewater is treated through multi-stage processes including mechanical screening, hydrolysis acidification, contact oxidation, and disinfection before being discharged to meet standards. Atmospheric emission points in laboratory buildings are numbered and tracked to control fugitive emissions. Noise emissions are ensured to meet standards through equipment updates, monitoring, and personal protective measures.
We actively address climate change by conducting comprehensive carbon inventories to understand emissions data. Scope 1 greenhouse gas emissions amount to 3,931.81 tCO2e, and Scope 2 emissions amount to 17,497.36 tCO2e. We promote energy-saving practices such as “turn off lights and equipment when leaving,” temperature control for air conditioning, utilize high-efficiency equipment, and explore the application of renewable energy.
(B) Safety Production and Occupational Health
Policies such as the Safety Production Rules and Regulations Management System and Occupational Health Medical Management Procedure are established. A comprehensive safety production training system is in place, with 89 safety training sessions totaling 10,891 hours and involving 2,248 participants, covering topics such as emergency response and hazardous chemical management.
We prioritize employee occupational health. New hires are required to provide pre-employment medical reports and obtain health certificates. Regular occupational health check-ups are arranged based on job characteristics, achieving 100% coverage for occupational health examinations. The occupational disease incidence rate was 0 during the reporting period. Work injury handling procedures are established, detailing steps from emergency care and health assessment to return-to-work arrangements, safeguarding employee health rights.
Emergency management mechanisms are enhanced with the Contingency Plans for Environmental Emergencies. Drills for scenarios like fires, explosions, and chemical spills are conducted, including hazardous chemical spill drills, infectious biological material spill drills, and comprehensive emergency drills, enhancing emergency response capabilities and ensuring operational safety.
IX. Employee Responsibility and Development
Embracing the philosophy that “employees are the company’s most valuable asset,” we are committed to creating a fair, inclusive, and diverse environment for employee development. We have built a full-cycle employee management system covering compliant hiring, compensation incentives, training and promotion, and welfare benefits.
(A) Compliant Hiring and Diversity
We strictly adhere to domestic and international labor laws, including the Labor Contract Law of the People’s Republic of China, prohibiting child labor and forced labor, with a 100% labor contract signing rate. Upholding equal employment principles, we do not discriminate based on race, gender, age, disability, etc. We employ 14 disabled individuals and 42 ethnic minority employees, fostering a diverse workforce.
(B) Compensation, Performance, and Incentives
We design a compensation system that is internally equitable and externally competitive, positioning pay levels to be market-leading. This includes base salary, allowances, project bonuses, and annual performance bonuses as short-term incentives, along with long-term incentive retention plans for key talent. Employee target bonuses are linked to individual and team performance, creating a “personal-team-company” win-win incentive mechanism.
(C) Training and Promotion
We have built a “comprehensive coverage, diverse formats” training system, leveraging an online digital training and examination platform. Training activities include internal training, external programs, and online courses, covering leadership, general skills, professional skills, and new employee orientation. During the reporting period, 420 training sessions were conducted, with total training expenditure of RMB 135,127.15. The average training hours per employee reached 40 hours, with 100% training coverage.
The “Set Sail Program” was launched, selecting 50 core employees from the post-90s generation grassroots management for leadership development through online assessments, systematic training, practical projects, and 1-on-1 mentorship. We have established five career development pathways (Management, R&D, Functions, Sales, Production), providing clear promotion routes for diverse talents, with annual promotion opportunities for high performers.
(D) Benefits and Democratic Management
We enhance the employee benefits package, offering statutory benefits such as social insurance, housing fund, public holidays, paid annual leave, and pre-, during, and post-employment occupational health check-ups. Additional benefits include meal, communication, transportation, and housing allowances, as well as traditional festival gifts. For female employees, we provide enhanced leave benefits beyond local standards, generous maternity allowances, and dedicated nursing rooms, creating a family-friendly work environment.
Various employee activities are organized, including football clubs, annual galas, team-building events, English corners, and health care initiatives like traditional Chinese medicine consultations, fostering team cohesion and a sense of belonging. We promote democratic management through mechanisms like employee representative congresses, employee forums, and suggestion channels. Regular employee satisfaction surveys are conducted; during the reporting period, the satisfaction rate reached 89.2%, and feedback regarding compensation, benefits, and career development is continuously used to optimize relevant policies.